Cover Image

Targeted proteomics profiling reveals valuable biomarkers in the diagnosis of primary immune thrombocytopaenia

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Yizhi Jiang, Jizhe Li, Jun Huang, Zichan Zhang, Xiaocen Liu, Nana Wang, Chen Huang, Ran Wang, Lanxin Zhang, JingJing Han, Xia Bai, Dongping Huang, Lu Zhou
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	British Journal of Haematology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A novel scoring model for predicting efficacy and guiding individualised treatment in immune thrombocytopaenia
by: Min Xu, et al.
Published: (2024)

Urine proteomics uncovers biomarker candidates for early identifying rituximab beneficiaries in paediatric steroid‐resistant immune thrombocytopenia
by: Yuncui Yu, et al.
Published: (2025)

Feasibility of plasma proteomics in patients with immune thrombocytopenia
by: Rick Kapur
Published: (2024)

Integrating chemokines and machine learning algorithms for diagnosis and bleeding assessment in primary immune thrombocytopenia: A prospective cohort study
by: Qing Wen, et al.
Published: (2024)

Longitudinal plasma proteomics in romiplostim‐treated patients with immune thrombocytopenia
by: Vivianne S. Nelson, et al.
Published: (2025)

COVID‐19 vaccination in splenectomized patients with immune thrombocytopenia—Response
by: Xiang Liu, et al.
Published: (2024)

Comprehensive analysis and prediction model of mitophagy and ferroptosis in primary immune thrombocytopenia
by: Jiani Mo, et al.
Published: (2024)

Efficacy and safety of avatrombopag in Chinese children with persistent and chronic primary immune thrombocytopenia: A multicentre observational retrospective study in China
by: Zhifa Wang, et al.
Published: (2024)

Effects of orelabrutinib, a BTK inhibitor, on antibody‐mediated platelet destruction in primary immune thrombocytopenia
by: Tian‐shu Yu, et al.
Published: (2025)

Longitudinal evaluation of adverse events due to steroid use in primary immune thrombocytopenia: A population‐based study
by: Jiaan‐Der Wang, et al.
Published: (2024)

The role of proliferating stem‐like plasma cells in relapsed or refractory multiple myeloma: Insights from single‐cell RNA sequencing and proteomic analysis
by: Jiadai Xu, et al.
Published: (2024)

Immune repertoire profiling in immune thrombocytopenia: A path towards biomarkers, for The British Journal of Haematology
by: Amna Malik, et al.
Published: (2026)

Long‐term efficacy and safety of hetrombopag in paediatric patients with immune thrombocytopenia
by: Jin‐Hua Wang, et al.
Published: (2026)

MicroRNA ‐199a‐5p may be a diagnostic biomarker of primary ITP
by: Lamya Garabet, et al.
Published: (2025)

Difficult‐to‐treat primary immune thrombocytopenia in adults: Prevalence and burden. Results from the CARMEN‐France registry
by: Guillaume Moulis, et al.
Published: (2024)

Reduced dose prednisone plus eltrombopag for the treatment of newly diagnosed adult primary immune thrombocytopenia: A prospective, multicentre, phase 2 clinical trial
by: Qi Liu, et al.
Published: (2025)

Clinical profiling and outcomes of ischaemic stroke patients with immune thrombocytopenia: A multicentre retrospective study
by: LiQin Cao, et al.
Published: (2026)

Cytogenetic abnormality in non‐systemic light chain amyloidosis monoclonal gammopathy of renal significance: A field needs to be explored
by: Xianghua Huang
Published: (2024)

Targeting small ubiquitin‐related modifier‐specific protease 2 attenuates tumour progression and orchestrates the tumour immune microenvironment in diffuse large B‐cell lymphoma
by: Xue Sheng, et al.
Published: (2025)

Epidemiological features and prognosis for primary gastrointestinal follicular lymphoma
by: Xuelei Li, et al.
Published: (2024)

Single‐cell transcriptome profiling reveals blast cell heterogeneity and identifies novel therapeutic target IKZF2 in t(8;21) acute myeloid leukaemia
by: Yu Liu, et al.
Published: (2025)

Early M‐protein immune reconstitution after autologous haematopoietic stem cell transplantation is a good prognostic marker for patients with high‐risk cytogenetic multiple myeloma
by: Huihui Zhu, et al.
Published: (2024)

Outcomes and risk factors of second allogeneic haematopoietic stem cell transplantation in patients with relapsed haematological malignancy after first transplantation
by: Xiaolu Zhu, et al.
Published: (2025)

Efficacy of immune checkpoint inhibitors in paediatric, adolescent and young adults with primary refractory or relapsed classical Hodgkin lymphoma: A national multicentre real‐world study
by: Marlène Pouthier, et al.
Published: (2026)

MicroRNAs as potential architects of immune dysregulation and megakaryocytic failure in immune thrombocytopenia
by: Zhenyu Liu, et al.
Published: (2026)

Exploratory study on the individualized application of eltrombopag in paediatric immune thrombocytopenia guided by therapeutic drug monitoring
by: Shuyue Dong, et al.
Published: (2024)

Droplet digital PCR: An effective method for monitoring and prognostic evaluation of minimal residual disease in JMML
by: Shengqiao Mao, et al.
Published: (2024)

Nicotinamide enhances Treg differentiation by promoting Foxp3 acetylation in immune thrombocytopenia
by: Ju Li, et al.
Published: (2024)

Nucleoside reverse transcriptase inhibition enhances platelet production and megakaryocyte maturation in patients with COVID‐19
by: Yubin Li, et al.
Published: (2025)

Quality of life in childhood immune thrombocytopenia: Revision of the Kids' ITP Tools (KIT)
by: Vinita Dhir, et al.
Published: (2024)

A multicentre randomized open‐label phase 2 trial of dexamethasone plus glycyrrhizinate versus dexamethasone in newly diagnosed immune thrombocytopenia
by: Haoyi Wang, et al.
Published: (2026)

Kabuki syndrome complicated by severe immune thrombocytopenia and autoimmune thyroiditis: Identification of a novel pathogenic mutation
by: Xinmiao Qu, et al.
Published: (2024)

The early and rapid response to daratumumab in children with chronic refractory immune thrombocytopenia from a referral single centre of China
by: Yu Hu, et al.
Published: (2024)

Precision immune‐guided management of cytomegalovirus ( CMV ) after allogeneic haematopoietic stem cell transplantation in the letermovir era: A pragmatic framework
by: Xinyi Jiang, et al.
Published: (2026)

Concurrent antiviral–immunochemotherapy strategy safely overcomes high hepatitis B viral load barrier in diffuse large B‐cell lymphoma: A multicentre cohort study
by: Yuxiao Zhao, et al.
Published: (2026)

Evaluation of MYD88 p. L265P detection by digital droplet polymerase chain reaction in cerebrospinal fluid for integrated diagnosis of primary large B‐cell lymphoma of the central nervous system
by: Vincent Harlay, et al.
Published: (2025)

Biochemical bone biomarkers in plasma cell dyscrasias
by: Guido Nador, et al.
Published: (2026)

Echinococcus granulosus antigen B regulates T‐cell function through inhibition of signal transducer and activator of transcription 3 in experimental immune thrombocytopenia
by: Yingbin Yue, et al.
Published: (2025)

Monitoring the KMT2A gene post‐chemotherapy independently predicts the relapse and survival risk after allogeneic haematopoietic stem cell transplantation
by: Jing Liu, et al.
Published: (2025)

Chemotherapy‐induced thrombocytopenia: modern diagnosis and treatment
by: Andrew B. Song, et al.
Published: (2025)